CSY China Sky One Medicl

HARBIN, China, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (AMEX:CSY), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced that it will conduct a conference call at 10:00 a.m. Eastern Time on August 12, 2008 to discuss its second quarter 2008 financial results. Joining Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky One Medical, Inc., will be Yu-bo Hao, Board Secretary. The Company plans to issue an earnings announcement prior to the call. To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-573-1052. International callers should dial 702-696-4500. The Conference ID for this call is 59672695. If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Tuesday, August 12, 2008 at 12 p.m. Eastern Time. To access the replay, dial 800-642-1687, international callers dial 706-645-9291 Conference ID 59672695. About China Sky One Medical, Inc. China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR") and Harbin First Bio-Engineering Company Limited ("First"), the Company manufactures and distributes over-the-counter pharmaceutical products as its primary revenue source. For more information, visit http://www.skyonemedical.com/ . Safe Harbor Statement Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time. For more information, please contact: Company Contact: China Sky One Medical, Inc. Mr. Yubo Hao, Board Secretary Tel: +86-451-5399-4069 Email: Investor Relations Contact: CCG Investor Relations Mr. Crocker Coulson, President Tel: +1-646-213-1915 Email: Mr. Richard Micchelli, Financial Writer Tel: +1-646-454-4516 Email: Web: http://www.ccgir.com/ DATASOURCE: China Sky One Medical, Inc. CONTACT: Mr. Yubo Hao, Board Secretary of China Sky One Medical, Inc., +86-451-5399-4069, or ; Investor Relations Contact, Mr. Crocker Coulson, President, +1-646-213-1915, or , or Mr. Richard Micchelli, Financial Writer, +1-646-454-4516, or , both of CCG for CSY Web Site: http://www.skyonemedical.com/ http://www.ccgir.com/

Copyright